Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • UCB enters TCE space with $1.1B deal for Chinese biotech’s autoimmune candidate

UCB enters TCE space with $1.1B deal for Chinese biotech’s autoimmune candidate

  • March 4, 2026

UCB has entered the red-hot T-cell engager space by paying $80 million for the rights to a Chinese biotech’s preclinical autoimmune candidate.

Leave A Comment

Fields (*) Mark are Required